Recent changes in the treatment of patients with advanced laryngeal cancer
Eric M. Genden(Icahn School of Medicine at Mount Sinai), Gregory T. Wolf(University of Michigan), Alfio Ferlito(University of Padua), Carl E. Silver(Albert Einstein College of Medicine), Alessandra Rinaldo(University of Udine), Amy Y. Chen(Vector (United States)), Johannes J. Fagan(University of Cape Town), C. René Leemans(Amsterdam University Medical Centers), Patrick J. Bradley(Nottingham University Hospitals NHS Trust), Jean Louis Lefèbvre(Centre Oscar Lambret), Johannes A. Langendijk(University of Groningen), Jemy Jose(Hull Royal Infirmary), Carlos Suárez(Hospital Universitario Central de Asturias)
Cited by 44
Related Papers
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
|Head & Neck|2005|1.8k
The molecular landscape of head and neck cancer
|Nature reviews. Cancer|2018|1.4k
Impact of Late Treatment-Related Toxicity on Quality of Life Among Patients With Head and Neck Cancer Treated With Radiotherapy
|Journal of Clinical Oncology|2008|687
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
|Journal of Clinical Oncology|2006|504
Clinical Predictors of Quality of Life in Patients With Head and Neck Cancer
|Archives of Otolaryngology - Head and Neck Surgery|2004|454